Hulin Wu
Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
HIV-1 | 24 | 1999 | 93 |
Why?
| Models, Biological | 18 | 1999 | 410 |
Why?
| HIV Infections | 22 | 1998 | 136 |
Why?
| Acquired Immunodeficiency Syndrome | 9 | 1999 | 85 |
Why?
| Anti-HIV Agents | 13 | 1998 | 44 |
Why?
| HIV | 6 | 1998 | 32 |
Why?
| Computer Simulation | 9 | 1999 | 134 |
Why?
| Viral Load | 14 | 1998 | 53 |
Why?
| RNA, Viral | 12 | 1999 | 91 |
Why?
| Virus Replication | 6 | 1999 | 90 |
Why?
| Biometry | 6 | 1997 | 32 |
Why?
| Antiretroviral Therapy, Highly Active | 7 | 2001 | 27 |
Why?
| Bayes Theorem | 5 | 2002 | 24 |
Why?
| Nonlinear Dynamics | 6 | 1999 | 18 |
Why?
| HIV Protease Inhibitors | 8 | 1999 | 25 |
Why?
| Internet | 2 | 2005 | 64 |
Why?
| Clinical Trials as Topic | 7 | 1999 | 251 |
Why?
| Software | 1 | 2010 | 92 |
Why?
| Flow Cytometry | 3 | 2006 | 216 |
Why?
| Reverse Transcriptase Inhibitors | 6 | 1999 | 19 |
Why?
| Virus Physiological Phenomena | 1 | 2008 | 5 |
Why?
| Models, Statistical | 5 | 1997 | 114 |
Why?
| Influenza, Human | 2 | 2006 | 94 |
Why?
| Ritonavir | 6 | 1999 | 10 |
Why?
| T-Lymphocytes | 2 | 2006 | 182 |
Why?
| Influenza A virus | 1 | 2009 | 63 |
Why?
| Anti-Retroviral Agents | 1 | 2006 | 13 |
Why?
| Humans | 36 | 1998 | 1856 |
Why?
| CD4 Lymphocyte Count | 7 | 1999 | 50 |
Why?
| Databases as Topic | 1 | 2005 | 27 |
Why?
| Indinavir | 4 | 2003 | 6 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 224 |
Why?
| Antiviral Agents | 3 | 1999 | 91 |
Why?
| Drug Resistance, Viral | 3 | 2005 | 17 |
Why?
| Linear Models | 4 | 2003 | 151 |
Why?
| Viremia | 2 | 1999 | 18 |
Why?
| Data Interpretation, Statistical | 4 | 1997 | 109 |
Why?
| Least-Squares Analysis | 3 | 2002 | 21 |
Why?
| Monte Carlo Method | 3 | 1998 | 40 |
Why?
| Succinimides | 2 | 2006 | 12 |
Why?
| Models, Immunological | 1 | 1998 | 40 |
Why?
| Fluoresceins | 2 | 2006 | 50 |
Why?
| Antigens, CD | 1 | 1999 | 128 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 1998 | 113 |
Why?
| Mathematics | 2 | 2005 | 75 |
Why?
| Cell Proliferation | 3 | 2006 | 227 |
Why?
| Algorithms | 3 | 2006 | 226 |
Why?
| B-Lymphocytes | 2 | 2009 | 134 |
Why?
| Cell Division | 2 | 2006 | 273 |
Why?
| Drug Therapy, Combination | 8 | 1999 | 189 |
Why?
| Mutation | 4 | 2000 | 340 |
Why?
| Benzoxazines | 2 | 2003 | 14 |
Why?
| Regression Analysis | 2 | 2004 | 256 |
Why?
| Longitudinal Studies | 2 | 2002 | 195 |
Why?
| Patient Compliance | 2 | 2003 | 113 |
Why?
| HIV Protease | 2 | 2000 | 7 |
Why?
| Drug Administration Schedule | 5 | 1999 | 191 |
Why?
| Zidovudine | 3 | 1999 | 23 |
Why?
| Models, Theoretical | 2 | 2009 | 124 |
Why?
| Influenza A Virus, H3N2 Subtype | 1 | 2010 | 21 |
Why?
| Lymphocyte Subsets | 1 | 2009 | 26 |
Why?
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2009 | 17 |
Why?
| Blood | 1 | 2009 | 67 |
Why?
| Fluorescent Dyes | 2 | 2006 | 115 |
Why?
| Orthomyxoviridae Infections | 1 | 2010 | 29 |
Why?
| Mice | 5 | 1997 | 623 |
Why?
| Kinetics | 2 | 2006 | 349 |
Why?
| Fascia | 1 | 2007 | 15 |
Why?
| Fasciitis, Plantar | 1 | 2007 | 4 |
Why?
| HIV Long-Term Survivors | 1 | 2007 | 3 |
Why?
| Nucleoside Deaminases | 1 | 2007 | 10 |
Why?
| Mice, Inbred C57BL | 2 | 2009 | 318 |
Why?
| Foot | 1 | 2007 | 28 |
Why?
| Predictive Value of Tests | 1 | 2009 | 321 |
Why?
| Influenza Vaccines | 1 | 2009 | 70 |
Why?
| Smallpox Vaccine | 1 | 2006 | 7 |
Why?
| Smallpox | 1 | 2006 | 8 |
Why?
| Vaccinia | 1 | 2006 | 7 |
Why?
| Lamivudine | 3 | 1999 | 18 |
Why?
| Cell Line | 2 | 2006 | 375 |
Why?
| Infant, Newborn | 3 | 1999 | 389 |
Why?
| Allergy and Immunology | 1 | 2005 | 3 |
Why?
| Access to Information | 1 | 2005 | 4 |
Why?
| Half-Life | 2 | 1999 | 69 |
Why?
| Infant | 3 | 1999 | 464 |
Why?
| Repressor Proteins | 1 | 2007 | 96 |
Why?
| Recombination, Genetic | 1 | 2006 | 78 |
Why?
| Child, Preschool | 3 | 1999 | 554 |
Why?
| Stochastic Processes | 2 | 1998 | 22 |
Why?
| Genes, MDR | 1 | 2003 | 9 |
Why?
| Adult | 8 | 2000 | 1317 |
Why?
| Dideoxynucleosides | 1 | 2003 | 8 |
Why?
| Rifabutin | 1 | 2003 | 4 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2006 | 176 |
Why?
| Time Factors | 3 | 2003 | 896 |
Why?
| Oxazines | 1 | 2003 | 16 |
Why?
| Hispanic Americans | 1 | 2004 | 57 |
Why?
| Biomedical Research | 1 | 2005 | 87 |
Why?
| Female | 9 | 1997 | 1643 |
Why?
| Animals | 5 | 1997 | 1031 |
Why?
| Probability | 2 | 1998 | 190 |
Why?
| African Continental Ancestry Group | 1 | 2004 | 80 |
Why?
| Risk-Taking | 1 | 2004 | 36 |
Why?
| Immunoglobulin G | 2 | 1999 | 191 |
Why?
| Adolescent | 4 | 2003 | 891 |
Why?
| European Continental Ancestry Group | 1 | 2004 | 117 |
Why?
| Protease Inhibitors | 1 | 2002 | 39 |
Why?
| Lung | 1 | 2009 | 232 |
Why?
| Retrospective Studies | 2 | 2003 | 653 |
Why?
| Phenotype | 1 | 2003 | 303 |
Why?
| Male | 8 | 2000 | 1553 |
Why?
| Complement Pathway, Classical | 1 | 1999 | 7 |
Why?
| Complement System Proteins | 1 | 1999 | 30 |
Why?
| NAD+ Nucleosidase | 1 | 1999 | 6 |
Why?
| ADP-ribosyl Cyclase | 1 | 1999 | 6 |
Why?
| Antigens, CD38 | 1 | 1999 | 7 |
Why?
| Multivariate Analysis | 1 | 2001 | 225 |
Why?
| Antigens, Differentiation | 1 | 1999 | 53 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 1999 | 27 |
Why?
| Anti-Bacterial Agents | 1 | 2003 | 195 |
Why?
| Normal Distribution | 1 | 1998 | 13 |
Why?
| Ethylene Glycol | 1 | 1997 | 6 |
Why?
| Ethylene Glycols | 1 | 1997 | 10 |
Why?
| Diethylhexyl Phthalate | 1 | 1997 | 2 |
Why?
| Staining and Labeling | 2 | 2006 | 101 |
Why?
| Likelihood Functions | 1 | 1997 | 43 |
Why?
| Abnormalities, Drug-Induced | 1 | 1997 | 16 |
Why?
| Cluster Analysis | 1 | 1997 | 66 |
Why?
| Middle Aged | 6 | 2000 | 1161 |
Why?
| Body Weight | 1 | 1997 | 178 |
Why?
| Leukocytes, Mononuclear | 2 | 2006 | 67 |
Why?
| Fetus | 1 | 1997 | 105 |
Why?
| Membrane Glycoproteins | 1 | 1999 | 154 |
Why?
| United States | 1 | 2004 | 604 |
Why?
| Antibodies, Viral | 2 | 2006 | 104 |
Why?
| HIV Reverse Transcriptase | 2 | 2000 | 16 |
Why?
| Child | 1 | 2004 | 749 |
Why?
| Drug Interactions | 2 | 2003 | 111 |
Why?
| Pyridazines | 1 | 2011 | 8 |
Why?
| Nevirapine | 1 | 2011 | 9 |
Why?
| Pregnancy | 1 | 1997 | 455 |
Why?
| Virology | 1 | 2010 | 13 |
Why?
| Mutation, Missense | 1 | 2011 | 59 |
Why?
| Virulence | 1 | 2010 | 48 |
Why?
| Hong Kong | 1 | 2009 | 11 |
Why?
| Immunoglobulin M | 1 | 2010 | 81 |
Why?
| Cross Reactions | 1 | 2009 | 63 |
Why?
| Demecolcine | 1 | 2009 | 5 |
Why?
| Thymidine | 1 | 2009 | 47 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 2010 | 52 |
Why?
| Immunologic Memory | 1 | 2009 | 51 |
Why?
| Cell Count | 1 | 2009 | 163 |
Why?
| Interleukin-4 | 1 | 2009 | 62 |
Why?
| Lipopolysaccharides | 1 | 2009 | 98 |
Why?
| Metatarsophalangeal Joint | 1 | 2007 | 7 |
Why?
| Epithelial Cells | 1 | 2010 | 135 |
Why?
| Ankle | 1 | 2007 | 14 |
Why?
| Cadaver | 1 | 2007 | 51 |
Why?
| Exercise Therapy | 1 | 2007 | 28 |
Why?
| Range of Motion, Articular | 1 | 2007 | 43 |
Why?
| Virus Cultivation | 1 | 2006 | 24 |
Why?
| HIV Core Protein p24 | 1 | 2006 | 17 |
Why?
| Antigens, Thy-1 | 1 | 2006 | 22 |
Why?
| Vaccinia virus | 1 | 2006 | 22 |
Why?
| Cytidine Deaminase | 1 | 2007 | 15 |
Why?
| Immunity, Cellular | 1 | 2006 | 85 |
Why?
| Genes, Reporter | 1 | 2006 | 111 |
Why?
| Antibody Formation | 1 | 2006 | 89 |
Why?
| Substance Abuse, Intravenous | 1 | 2004 | 15 |
Why?
| Disease Progression | 1 | 2007 | 244 |
Why?
| Biological Markers | 1 | 2007 | 262 |
Why?
| Interferon-gamma | 1 | 2006 | 133 |
Why?
| Vaccination | 1 | 2006 | 92 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2003 | 39 |
Why?
| Ethnic Groups | 1 | 2004 | 95 |
Why?
| P-Glycoprotein | 1 | 2003 | 19 |
Why?
| Bias (Epidemiology) | 1 | 2003 | 35 |
Why?
| Area Under Curve | 1 | 2003 | 47 |
Why?
| Alleles | 1 | 2003 | 108 |
Why?
| Cross-Over Studies | 1 | 2003 | 82 |
Why?
| Sensitivity and Specificity | 1 | 2006 | 427 |
Why?
| Apoptosis | 1 | 2009 | 265 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2004 | 91 |
Why?
| Administration, Oral | 1 | 2003 | 170 |
Why?
| Cells, Cultured | 1 | 2009 | 447 |
Why?
| Logistic Models | 1 | 2003 | 251 |
Why?
| HIV Antigens | 1 | 1999 | 8 |
Why?
| HIV Antibodies | 1 | 1999 | 16 |
Why?
| Drug Resistance, Microbial | 1 | 2000 | 53 |
Why?
| RNA, Messenger | 1 | 2007 | 394 |
Why?
| Molecular Sequence Data | 1 | 2000 | 404 |
Why?
|
|
Wu's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
